Floatz logo

Tesamorelin

Impaired Physical Function

Massachusetts General Hospitalprotein_peptidePhase 2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Impaired Physical Function cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Tesamorelin is also rated in:

lipodystrophyDormant
B
Indicative ·
62 / 100
View asset →
Body CompositionDormant
B
Indicative ·
60 / 100
View asset →
isolated congenital growth hormone deficiencyDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →